The factor Xa inhibitor rivaroxaban at a dose of 2.5 mg orally twice a day decreases risk of cardiovascular events (cardiovascular death, stroke, or myocardial infarction) in patients with stable atherosclerotic vascular disease when added to aspirin 100 mg daily.